What is the best antibiotic for skin infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Antibiotic for Skin Infections

For most uncomplicated skin infections, dicloxacillin, cephalexin, or clindamycin are the preferred first-line antibiotics, with specific choices depending on the suspected pathogen and severity of infection. 1

Antibiotic Selection Based on Infection Type

Impetigo

  • First-line options:
    • Dicloxacillin: 250 mg 4 times daily (adults) 1
    • Cephalexin: 250-500 mg 4 times daily (adults); 25-50 mg/kg/day in 3-4 divided doses (children) 1
    • Mupirocin ointment: Apply to lesions twice daily (for limited number of lesions) 1
  • Alternative options:
    • Clindamycin: 300-400 mg 3 times daily (adults); 20 mg/kg/day in 3 divided doses (children) 1
    • Amoxicillin-clavulanate: 875/125 mg twice daily (adults); 25 mg/kg/day of amoxicillin component in 2 divided doses (children) 1

Cellulitis (Non-purulent)

  • Mild cases (no systemic signs): Antimicrobial agent active against streptococci 1
    • Penicillin: 250-500 mg every 6 hours orally 1
    • Cephalexin: 500 mg 4 times daily 1
  • Moderate cases (with systemic signs): Consider coverage for both streptococci and MSSA 1
    • Cefazolin: 1 g every 8 hours IV 1
    • Clindamycin: 600 mg every 8 hours IV 1
  • Severe cases or MRSA risk factors: Coverage for both MRSA and streptococci 1
    • Vancomycin: 30 mg/kg/day in 2 divided doses IV 1
    • Linezolid: 600 mg every 12 hours IV or orally 1, 2

Purulent Skin Infections (Abscesses)

  • Primary treatment: Incision and drainage 1
  • Adjunctive antibiotics for moderate-severe cases:
    • Trimethoprim-sulfamethoxazole: 1-2 double-strength tablets twice daily 1
    • Doxycycline: 100 mg twice daily (not for children <8 years) 1
    • Clindamycin: 300-450 mg 3 times daily 1

MRSA Skin Infections

  • Outpatient treatment:
    • Clindamycin: 300-450 mg 3 times daily orally 1
    • Trimethoprim-sulfamethoxazole: 1-2 double-strength tablets twice daily 1
    • Doxycycline: 100 mg twice daily (not for children <8 years) 1
    • Linezolid: 600 mg twice daily 1, 2
  • Inpatient treatment:
    • Vancomycin: 30 mg/kg/day in 2 divided doses IV 1
    • Linezolid: 600 mg every 12 hours IV or orally 1, 2
    • Daptomycin: 4 mg/kg every 24 hours IV 1
    • Ceftaroline: 600 mg twice daily IV 1

Special Considerations

Animal or Human Bites

  • First-line: Amoxicillin-clavulanate: 875/125 mg twice daily orally 1
  • Alternatives:
    • Ampicillin-sulbactam: 1.5-3.0 g every 6 hours IV 1
    • Doxycycline: 100 mg twice daily (excellent activity against Pasteurella multocida) 1
    • For human bites: Consider broader coverage including anaerobes 1

Necrotizing Infections

  • Immediate surgical debridement is crucial 1
  • Empiric broad-spectrum coverage:
    • Vancomycin plus piperacillin-tazobactam or a carbapenem 1
  • For confirmed streptococcal infection:
    • Penicillin plus clindamycin: 2-4 million units every 4-6 hours IV plus 600-900 mg every 8 hours IV 1
  • For confirmed staphylococcal infection:
    • Nafcillin: 1-2 g every 4 hours IV 1
    • For MRSA: Vancomycin: 30 mg/kg/day in 2 divided doses IV 1

Duration of Therapy

  • For most uncomplicated skin infections: 5-7 days 1
  • For complicated infections: 7-14 days, based on clinical response 1
  • For necrotizing infections: 2-3 weeks 1

Clinical Pearls and Pitfalls

  • Always consider local resistance patterns when selecting empiric therapy 1
  • Incision and drainage alone may be sufficient for simple abscesses without antibiotics 1
  • Topical antibiotics (mupirocin, retapamulin) are highly effective for limited impetigo lesions and may help prevent antibiotic resistance 3
  • Linezolid has equivalent oral and IV bioavailability, making it excellent for transitioning from IV to oral therapy 2, 4
  • Cephalexin twice daily dosing has shown similar efficacy to four-times-daily regimens in some studies, potentially improving compliance 5
  • Elevation of affected areas and treatment of predisposing factors (edema, underlying skin disorders) are important adjunctive measures 1
  • For recurrent MRSA infections, consider decolonization with intranasal mupirocin, daily chlorhexidine washes, and decontamination of personal items 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.